BACKGROUND: Isolates of methicillin-resistant Staphylococcus aureus (MRSA) belonging to a single lineage are often indistinguishable by means of current typing techniques. Whole-genome sequencing may provide improved resolution to define transmission pathways and characterize outbreaks. METHODS: We investigated a putative MRSA outbreak in a neonatal intensive care unit. By using rapid high-throughput sequencing technology with a clinically relevant turnaround time, we retrospectively sequenced the DNA from seven isolates associated with the outbreak and another seven MRSA isolates associated with carriage of MRSA or bacteremia in the same hospital. RESULTS: We constructed a phylogenetic tree by comparing single-nucleotide polymorphisms (SNPs) in the core genome to a reference genome (an epidemic MRSA clone, EMRSA-15 [sequence type 22]). This revealed a distinct cluster of outbreak isolates and clear separation between these and the nonoutbreak isolates. A previously missed transmission event was detected between two patients with bacteremia who were not part of the outbreak. We created an artificial "resistome" of antibiotic-resistance genes and demonstrated concordance between it and the results of phenotypic susceptibility testing; we also created a "toxome" consisting of toxin genes. One outbreak isolate had a hypermutator phenotype with a higher number of SNPs than the other outbreak isolates, highlighting the difficulty of imposing a simple threshold for the number of SNPs between isolates to decide whether they are part of a recent transmission chain. CONCLUSIONS: Whole-genome sequencing can provide clinically relevant data within a time frame that can influence patient care. The need for automated data interpretation and the provision of clinically meaningful reports represent hurdles to clinical implementation. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.).
BACKGROUND: Isolates of methicillin-resistant Staphylococcus aureus (MRSA) belonging to a single lineage are often indistinguishable by means of current typing techniques. Whole-genome sequencing may provide improved resolution to define transmission pathways and characterize outbreaks. METHODS: We investigated a putative MRSA outbreak in a neonatal intensive care unit. By using rapid high-throughput sequencing technology with a clinically relevant turnaround time, we retrospectively sequenced the DNA from seven isolates associated with the outbreak and another seven MRSA isolates associated with carriage of MRSA or bacteremia in the same hospital. RESULTS: We constructed a phylogenetic tree by comparing single-nucleotide polymorphisms (SNPs) in the core genome to a reference genome (an epidemic MRSA clone, EMRSA-15 [sequence type 22]). This revealed a distinct cluster of outbreak isolates and clear separation between these and the nonoutbreak isolates. A previously missed transmission event was detected between two patients with bacteremia who were not part of the outbreak. We created an artificial "resistome" of antibiotic-resistance genes and demonstrated concordance between it and the results of phenotypic susceptibility testing; we also created a "toxome" consisting of toxin genes. One outbreak isolate had a hypermutator phenotype with a higher number of SNPs than the other outbreak isolates, highlighting the difficulty of imposing a simple threshold for the number of SNPs between isolates to decide whether they are part of a recent transmission chain. CONCLUSIONS: Whole-genome sequencing can provide clinically relevant data within a time frame that can influence patient care. The need for automated data interpretation and the provision of clinically meaningful reports represent hurdles to clinical implementation. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.).
Authors: Thomas P Niedringhaus; Denitsa Milanova; Matthew B Kerby; Michael P Snyder; Annelise E Barron Journal: Anal Chem Date: 2011-05-25 Impact factor: 6.986
Authors: E Alcoceba; A Mena; M Cruz Pérez; E Ruiz de Gopegui; E Padilla; J Gil; A Ramírez; C Gallegos; A Serra; J L Pérez; A Oliver Journal: Clin Microbiol Infect Date: 2007-03-22 Impact factor: 8.067
Authors: B M Andersen; T Tollefsen; B Seljordslia; K Hochlin; G Syversen; T Ø Jonassen; M Rasch; L Sandvik Journal: J Infect Date: 2010-02-01 Impact factor: 6.072
Authors: Matthew T G Holden; Edward J Feil; Jodi A Lindsay; Sharon J Peacock; Nicholas P J Day; Mark C Enright; Tim J Foster; Catrin E Moore; Laurence Hurst; Rebecca Atkin; Andrew Barron; Nathalie Bason; Stephen D Bentley; Carol Chillingworth; Tracey Chillingworth; Carol Churcher; Louise Clark; Craig Corton; Ann Cronin; Jon Doggett; Linda Dowd; Theresa Feltwell; Zahra Hance; Barbara Harris; Heidi Hauser; Simon Holroyd; Kay Jagels; Keith D James; Nicola Lennard; Alexandra Line; Rebecca Mayes; Sharon Moule; Karen Mungall; Douglas Ormond; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Sarah Sharp; Mark Simmonds; Kim Stevens; Sally Whitehead; Bart G Barrell; Brian G Spratt; Julian Parkhill Journal: Proc Natl Acad Sci U S A Date: 2004-06-22 Impact factor: 11.205
Authors: Matthew J Ellington; Russell Hope; David M Livermore; Angela M Kearns; Katherine Henderson; Barry D Cookson; Andrew Pearson; Alan P Johnson Journal: J Antimicrob Chemother Date: 2009-12-24 Impact factor: 5.790
Authors: Laura García-Álvarez; Matthew T G Holden; Heather Lindsay; Cerian R Webb; Derek F J Brown; Martin D Curran; Enid Walpole; Karen Brooks; Derek J Pickard; Christopher Teale; Julian Parkhill; Stephen D Bentley; Giles F Edwards; E Kirsty Girvan; Angela M Kearns; Bruno Pichon; Robert L R Hill; Anders Rhod Larsen; Robert L Skov; Sharon J Peacock; Duncan J Maskell; Mark A Holmes Journal: Lancet Infect Dis Date: 2011-08 Impact factor: 25.071
Authors: Veronica N Kos; Maxime Déraspe; Robert E McLaughlin; James D Whiteaker; Paul H Roy; Richard A Alm; Jacques Corbeil; Humphrey Gardner Journal: Antimicrob Agents Chemother Date: 2014-11-03 Impact factor: 5.191
Authors: Keith A Jolley; Dorothea M C Hill; Holly B Bratcher; Odile B Harrison; Ian M Feavers; Julian Parkhill; Martin C J Maiden Journal: J Clin Microbiol Date: 2012-07-11 Impact factor: 5.948
Authors: Kyle J Popovich; Evan Snitkin; Stefan J Green; Alla Aroutcheva; Mary K Hayden; Bala Hota; Robert A Weinstein Journal: Clin Infect Dis Date: 2015-09-07 Impact factor: 9.079
Authors: C Hal Jones; Naglaa Mohamed; Eduardo Rojas; Lubomira Andrew; Johanna Hoyos; Julio C Hawkins; Lisa K McNeil; Qin Jiang; Leonard W Mayer; Xin Wang; Rodica Gilca; Philippe De Wals; Louise Pedneault; Joseph Eiden; Kathrin U Jansen; Annaliesa S Anderson Journal: J Clin Microbiol Date: 2015-08-26 Impact factor: 5.948
Authors: Scott A Cunningham; Nicholas Chia; Patricio R Jeraldo; Daniel J Quest; Julie A Johnson; Dave J Boxrud; Angela J Taylor; Jun Chen; Gregory D Jenkins; Travis M Drucker; Heidi Nelson; Robin Patel Journal: J Clin Microbiol Date: 2017-04-12 Impact factor: 5.948
Authors: Tim Dallman; Geoffrey P Smith; Brendan O'Brien; Marie A Chattaway; David Finlay; Kathie A Grant; Claire Jenkins Journal: J Clin Microbiol Date: 2012-10-03 Impact factor: 5.948
Authors: Anders Johansson; Adrian Lärkeryd; Micael Widerström; Sara Mörtberg; Kerstin Myrtännäs; Caroline Ohrman; Dawn Birdsell; Paul Keim; David M Wagner; Mats Forsman; Pär Larsson Journal: Clin Infect Dis Date: 2014-08-05 Impact factor: 9.079